PHUPPing the switch on Akt and protein kinase C signaling

被引：146

作者：

Brognard, John ^{[1
]}

Newton, Alexandra C. ^{[1
]}

机构：

[1] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA

来源：

TRENDS IN ENDOCRINOLOGY AND METABOLISM | 2008年 / 19卷 / 06期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1016/j.tem.2008.04.001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The Ser/Thr-specific phosphatase PHLPP pleckstrin homology (PH) domain leucine-rich repeat protein phosphatasel provides 'the brakes' for Akt and protein kinase C (PKC) signaling. The two isoforms of this recently discovered family, PHLPP1 and PHLPP2, control the amplitude and duration of signaling of Akt and PKC by catalyzing the dephosphorylation of the hydrophobic phosphorylation motif, a C-terminal phosphorylation switch that controls these kinases. Aberrant regulation of either kinase accompanies many diseases, notably diabetes and cancer. By specifically dephosphorylating the hydrophobic motif, PHLPP controls the degree of agonist-evoked signaling by Akt and the cellular levels of PKC. This review focuses on the function of PHLPP1 and PHLPP2 in modulating signaling by Akt and PKC.

引用

页码：223 / 230

页数：8

共 50 条

[41] Pathway illuminated: Visualizing protein kinase C signaling
Violin, JD
Newton, AC
IUBMB LIFE, 2003, 55 (12) : 653 - 660
[42] Regulation of Ras signaling specificity by protein kinase C
Rusanescu, G
Gotoh, T
Tian, XJ
Feig, LA
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (08) : 2650 - 2658
[43] Smack in the middle of schistosomes:: Protein kinase C signaling
Omar, HH
Humphries, JE
Day, TA
PROCEEDINGS OF THE 10TH INTERNATIONAL CONGRESS OF PARASITOLOGY-ICOPA X: SYMPOSIA, WORKSHOPS AND CONTRIBUTED PAPERS, 2002, : 111 - 115
[44] Protein kinase C signaling in the treatment of bipolar disorder
Manji, H
Bebchuk, J
Chen, G
BIOLOGICAL PSYCHIATRY, 1998, 43 : 87S - 87S
[45] Protein kinase C α controls erythropoietin receptor signaling
von Lindern, M
Parren-van Amelsvoort, M
van Dijk, T
Deiner, E
van den Akker, E
van Emst-de Vries, S
Willems, P
Beug, H
Löwenberg, B
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (44) : 34719 - 34727
[46] Identification of an inactivating cysteine switch in protein kinase Cε, a rational target for the design of protein kinase Cε-inhibitory cancer therapeutics
Chu, F
Koomen, JM
Kobayashi, R
O'Brian, CA
CANCER RESEARCH, 2005, 65 (22) : 10478 - 10485
[47] Akt/protein kinase B
Abraham, E
CRITICAL CARE MEDICINE, 2005, 33 (12) : S420 - S422
[48] Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt protein kinase B
Jiang, BH
Aoki, M
Zheng, JZ
Li, J
Vogt, PK
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (05) : 2077 - 2081
[49] Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt
Yang, L
Dan, HC
Sun, M
Liu, QY
Sun, XM
Feldman, RI
Hamilton, AD
Polokoff, M
Nicosia, SV
Herlyn, M
Sebti, SM
Cheng, JQ
CANCER RESEARCH, 2004, 64 (13) : 4394 - 4399
[50] PreImplantation Factor bolsters neuroprotection via modulating Protein Kinase A and Protein Kinase C signaling
Mueller, M.
Schoeberlein, A.
Zhou, J.
Joerger-Messerli, M.
Oppliger, B.
Reinhart, U.
Bordey, A.
Surbek, D.
Barnea, E. R.
Huang, Y.
Paidas, M.
CELL DEATH AND DIFFERENTIATION, 2015, 22 (12): : 2078 - 2086

← 1 2 3 4 5 →